Search clinical trials for: infliximab or placebo

Total 58808 results

Merck Sharp & Dohme LLC

Terminated

Treatment With Infliximab in a Medical Setting (Study P05587) (OPTIMIST)

Crohn's Disease
Pfizer

Completed

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Rheumatoid Arthritis

Jordan, Korea, Republic of, United States, Poland, Japan, Hungary, South Africa, Ukraine, Germany, Israel, Philippines, Serbia, Australia, Georgia, Czechia, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Guatemala, Lithuania, M... and more
aTyr Pharma, Inc.
Foundation for Sarcoidosis Research

Completed

Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States
Copenhagen University Hospital at Herlev

Completed

Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission (STOP IT)

Crohn Disease

Sweden, Denmark, Finland, Norway
Xiaomin Zhang

Active, not recruiting

A Clinical Trial of Infliximab for Childhood Uveitis

Uveitis | Infliximab
Egla C. Rabinovich
Childhood Arthritis and Rheumatology Research Alliance

Completed

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

Chronic Uveitis

United States
Loyola University

Withdrawn

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Toxic Epidermal Necrolysis
Peking Union Medical College Hospital
Changhai Hospital; West China Hospital; Shenzhen People's Hospital; First People... and other collaborators

Unknown

Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis (ULTRA)

Rheumatoid Arthritis | Ultrasonography | Infliximab

China
Center for Integrated Rehabilitation and Organ...
Centocor, Inc.

Completed

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

Cachexia | COPD

Netherlands
AceLink Therapeutics, Inc.
Novotech (Australia) Pty Limited

Completed

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers

Autosomal Dominant Polycystic Kidney

Australia
Cares, Kristen, M.D.

Recruiting

Infliximab Proactive Drug Monitoring in the Pediatric IBD Population

Inflammatory Bone Disease

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab (PRECISION)

Inflammatory Bowel Disease

Netherlands
James Chodosh, MD, MPH
Massachusetts Eye and Ear Infirmary; Fonds de recherche en ophtalmologie de...

Withdrawn

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Stevens-Johnson Syndrome | Mucous Membrane Pemphigoid | Toxic Epidermal Necrolysis (Lyell) Syndrome

United States, Canada
University Hospital, Tours

Completed

Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis (FAKIR)

Rheumatoid Arthritis

France
KU Leuven

Completed

Effect of Anti TNFa Upon Deep Endometriosis Associated Pain (Infliximab)

Endometriosis

Belgium
Gu Jieruo

Completed

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

Spondylitis

China
Oregon Health and Science University
Centocor, Inc.

Completed

A Clinical Trial of Infliximab for Uveitis

Uveitis
Maier, Lisa, M.D.
Centocor, Inc.; National Center for Research Resources (NCRR)

Terminated

Beryllium Infliximab Study: Clinical Interventional Trial (BISCIT)

Berylliosis | Beryllium Disease

United States
Ali Amini Harandi

Unknown

MLC901 for Moderate to Severe Traumatic Brain Injury (Specified Drug Code) (MLC901)

Traumatic Brain Injury

Iran, Islamic Republic of
Copenhagen University Hospital at Herlev
Lundbeck Foundation; Danish Medical Association; Aase and Ejnar Danielsens Foundation and other collaborators

Unknown

Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

Crohn's Disease

Denmark
Pfizer

Active, not recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Rheumatoid Arthritis

Japan
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Anorexia | Fatigue | Lung Cancer | Cachexia

United States
Services Institute of Medical Sciences, Pakistan

Completed

Efficacy and Safety of Infliximab Biosimilar in the Treatment of Resistant Hidradenitis Suppurativa

Hidradenitis Suppurativa

Pakistan
Retina Research Foundation

Unknown

Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) (ITVR)

Macular Degeneration | Diabetic Retinopathy

United States
Genexine, Inc.

Completed

Safety and Tolerability of GX-P1 in Healthy Male Volunteers

Autoimmune Diseases

Korea, Republic of
Innovaderm Research Inc.
Schering-Plough

Completed

Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

Palmoplantar Psoriasis

Canada
Green Cross Corporation
Korean Center for Disease Control and Prevention

Completed

A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 (GC1109)

Anthrax

Korea, Republic of
Janssen Research & Development, LLC

Completed

A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)

Infarction | Ischemia | Stroke

United States
Creabilis SA
Aalborg University Hospital

Completed

A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers

Neuropathic Pain

Denmark
Hanmi Pharmaceutical Company Limited

Completed

Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects

Healthy

United States
University of California, San Diego
Nationwide Children's Hospital

Completed

Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease

Kawasaki Disease

United States
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

Psoriasis

China
Centocor, Inc.

Completed

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease

Crohn Disease
Imelda GI Clinical Research Center

Completed

Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis

Belgium
Merck Sharp & Dohme LLC

Terminated

Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

Psoriasis
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Ulcerative Colitis

China
Juventas Therapeutics, Inc.

Completed

Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia

Critical Limb Ischemia

United States, India
Cairo University

Completed

Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study

Uveitis | Behçet's Disease
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

Crohn's Disease
Devintec Sagl
Meditrial SrL

Recruiting

Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation

Recurrent Aphthous Ulcer

Italy
Newsoara Biopharma Co., Ltd.

Unknown

Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers

Healthy

China
Unity Biotechnology, Inc.

Terminated

Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo

Knee Osteoarthritis

United States
JULIANA AQUINO DE MOURA

Completed

The Effect of Non-hormonal Gel Application in Women in the Menacme With Sexual Dysfunction

Sexual Dysfunction
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers

Healthy
Hanmi Pharmaceutical Company Limited

Completed

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211

Obesity

United States
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Developing Oral LT3 Therapy for Heart Failure - HFrEF (DOT3HF-HFrEF)

Heart Failure With Reduced Ejection Fraction | Low Triiodothyronine Syndrome

United States
Massachusetts General Hospital

Withdrawn

Characterization of the Pharmacodynamic Response to Vaped THC

Vaping | THC
Akesobio Australia Pty Ltd

Completed

A Study of AK111 in Healthy Subjects

Psoriasis

New Zealand
Curadim Pharma Co., Ltd.

Unknown

A First-in-human Phase 1 Study of CP1050

Healthy Subjects

United Kingdom
GlaxoSmithKline

Completed

First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.

Pain, Inflammatory

United Kingdom

3

Subscribe